𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Novel kinase inhibitors in renal cell carcinoma: Progressive development of static agents

✍ Scribed by Apurva A. Desai; Walter M. Stadler

Book ID
107555012
Publisher
Springer
Year
2006
Tongue
English
Weight
116 KB
Volume
7
Category
Article
ISSN
1527-2737

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Time to disease progression to evaluate
Time to disease progression to evaluate a novel protein kinase C inhibitor, UCN-01, in renal cell carcinoma
✍ Brian I. Rini; Vivian Weinberg; Vanessa Shaw; Janet Scott; Robert Bok; John W. P πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 80 KB

## Abstract ## BACKGROUND Renal cell carcinoma (RCC) is characterized by von Hippel‐Lindau gene inactivation and vascular endothelial growth factor (VEGF) overproduction. The mechanism of VEGF overproduction may involve protein kinase C (PKC) delta and zeta isoforms. UCN‐01 (7‐hydroxystaurosporine